The Menarini Group Announces Meropenem/vaborbactam European Ma...
FLORENCE, Italy, December 12, 2018, /PRNewswire-AsiaNet/-- - Meropenem/vaborbactam approved on 20th November 2018 by the European Commission for clinical use in adult patients with difficult-to-treat infections- The first combination of a carbapenem and a beta-lactamase inhibitor approved for cl...
Read more https://view-release/?pr-id=76724